COPD

Nucala is an interleukin-5 antagonist under consideration as an add-on maintenance therapy for certain patients with chronic obstructive pulmonary disease.

High-dose omega-3 fatty acids during the third trimester of pregnancy could prevent respiratory problems.

Dupilumab is a monoclonal antibody previously approved to treat moderate-to-severe atopic dermatitis.

Many children with HIV who are diagnosed with asthma may actually have chronic obstructive lung disease.

Trial to analyze which commonly prescribed therapies can reduce exacerbations in patients with chronic obstructive pulmonary disease.

Concerns persist that excess folic acid supplementation may cause asthma in young children.

Healthcare workers may be at risk of chronic obstructive pulmonary disease due to exposure to cleaning products.

Exposing infants to high indoor levels of certain allergens may have a preventive effect on the development of asthma

Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is a single-inhaler triple therapy for the long-term, maintenance treatment of patients with chronic obstructive pulmonary disease.

Interventions to address asthma symptoms include allergen sensitivity testing and exposure remediation.

The thing is, you still may get sick after getting the flu because there are other things such as the common cold that might cross your path.

The cost and adverse events associated with corticosteroids need to be considered for patients with severe asthma.

Instructional methods can improve effectiveness of hand-held inhalers for asthma and chronic obstructive pulmonary disease.

Population growth and aging cause increase in disease burden from asthma and chronic obstructive pulmonary disease.

The prevalence of lung conditions worldwide has increased, despite the overall decrease in the prevalence and death rates for asthma between 1990 and 2015, according to the results of the 2015 Global Burden of Disease (GBD) Study.

Conclusive evidence that supports the use of probiotics to prevent eczema and asthma in high-risk infants is lacking.

Some patients with asthma have symptoms uncontrolled by inhaled corticosteroids and long-acting bronchodilators.

Patients with chronic obstructive pulmonary disease often have difficulty adhering to medications, which can lead to hospitalization.

Patients with chronic obstructive pulmonary disease (COPD) often have difficulty adhering to medications, leading to exacerbations, and often hospitalization.

Pharmacists can play a crucial role in promoting the flu vaccine to these patients by recognizing the characteristics of those who do not seek vaccinations.

Adherence is a major factor in outcomes for patients with chronic obstructive pulmonary disease.

AstraZeneca and GlaxoSmithKline are key players in the COPD market.

Chronic obstructive pulmonary disease market projected to reach $14.1 billion by 2025.

Women accounted for most of the hospitalization and in-hospital deaths.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

The action plan aims to reduce the burden of chronic obstructive pulmonary disease on patients and the healthcare system.

The risk of comorbid chronic obstructive pulmonary disorder in patients infected with HIV may be underestimated.